Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 30NIH 5NETWORK 4INDUSTRY 3OTHER_GOV 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 3Other neoplasm 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Carcinoma, Renal Cell 2Prostatic Neoplasms 1Neoplasm Metastasis 1Kidney Neoplasms 1

Interventions

pembrolizumab 164Prednisone 130enzalutamide 127Docetaxel 122Abiraterone Acetate 95Nivolumab 93Gemcitabine 71Sunitinib 67atezolizumab 50abiraterone 50Leuprolide 49acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 48Cisplatin 48radium Ra 223 dichloride 39Sorafenib 39darolutamide 38apalutamide 38Ipilimumab 38Carboplatin 37Prednisolone 33Everolimus 33Axitinib 32cabozantinib 31avelumab 31pazopanib 30Bevacizumab 30Paclitaxel 29enfortumab vedotin 28bicalutamide 28Cyclophosphamide 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Watchful Waiting × Genitourinary × Clear all
NCT02184416 2026-02-27

ADONIS

Pfizer

Completed
554 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02799745 2024-12-06

ENACT

Astellas Pharma Inc

Phase 2 Completed
227 enrolled 24 charts
Genitourinary

Prostatic Neoplasms

NCT00836745 2013-12-20

Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent

Pfizer

Completed
36 enrolled 7 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡